91 related articles for article (PubMed ID: 24439984)
1. Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study.
Dalsgaard M; Iversen K; Kjaergaard J; Grande P; Goetze JP; Clemmensen P; Hassager C
Am Heart J; 2014 Feb; 167(2):226-34. PubMed ID: 24439984
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).
Chockalingam A; Venkatesan S; Subramaniam T; Jagannathan V; Elangovan S; Alagesan R; Gnanavelu G; Dorairajan S; Krishna BP; Chockalingam V;
Am Heart J; 2004 Apr; 147(4):E19. PubMed ID: 15077102
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic effects of oral captopril in patients with critical aortic stenosis].
Martínez Sánchez C; Henne O; Arceo A; Peña M; González H; Chuquiure E; Lupi E
Arch Inst Cardiol Mex; 1996; 66(4):322-30. PubMed ID: 8984953
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function.
O'Brien KD; Zhao XQ; Shavelle DM; Caulfield MT; Letterer RA; Kapadia SR; Probstfield JL; Otto CM
J Investig Med; 2004 Apr; 52(3):185-91. PubMed ID: 15222408
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis.
Stewart RA; Kerr AJ; Cowan BR; Young AA; Occleshaw C; Richards AM; Edwards C; Whalley GA; Freidlander D; Williams M; Doughty RN; Zeng I; White HD;
Am Heart J; 2008 Aug; 156(2):348-55. PubMed ID: 18657667
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibition with ramipril improves left ventricular function at rest and post exercise in patients with stable ischaemic heart disease and preserved left ventricular systolic function.
Willenheimer R; Rydberg E; Oberg L; Juul-Möller S; Erhardt L
Eur Heart J; 1999 Nov; 20(22):1647-56. PubMed ID: 10543928
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation.
Schön HR
J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280
[TBL] [Abstract][Full Text] [Related]
8. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia.
Balling L; Kober L; Schou M; Torp-Pedersen C; Gustafsson F
J Card Fail; 2013 Nov; 19(11):725-30. PubMed ID: 24263115
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcome of higher versus lower transvalvular gradients in patients with severe aortic stenosis and low (<40%) left ventricular ejection fraction.
Ben-Dor I; Maluenda G; Iyasu GD; Laynez-Carnicero A; Hauville C; Torguson R; Okubagzi P; Xue Z; Goldstein SA; Lindsay J; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2012 Apr; 109(7):1031-7. PubMed ID: 22257710
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study.
Jiménez-Candil J; Bermejo J; Yotti R; Cortina C; Moreno M; Cantalapiedra JL; García-Fernández MA
Heart; 2005 Oct; 91(10):1311-8. PubMed ID: 16162624
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.
Jander N; Minners J; Holme I; Gerdts E; Boman K; Brudi P; Chambers JB; Egstrup K; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Rossebø A; Pedersen TR; Skjærpe T; Willenheimer R; Wachtell K; Neumann FJ; Gohlke-Bärwolf C
Circulation; 2011 Mar; 123(8):887-95. PubMed ID: 21321152
[TBL] [Abstract][Full Text] [Related]
14. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.
Khot UN; Novaro GM; Popović ZB; Mills RM; Thomas JD; Tuzcu EM; Hammer D; Nissen SE; Francis GS
N Engl J Med; 2003 May; 348(18):1756-63. PubMed ID: 12724481
[TBL] [Abstract][Full Text] [Related]
15. A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial).
Bull S; Loudon M; Francis JM; Joseph J; Gerry S; Karamitsos TD; Prendergast BD; Banning AP; Neubauer S; Myerson SG
Eur Heart J Cardiovasc Imaging; 2015 Aug; 16(8):834-41. PubMed ID: 25796267
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
[TBL] [Abstract][Full Text] [Related]
17. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation.
Gotzmann M; Lindstaedt M; Bojara W; Mügge A; Germing A
Am Heart J; 2010 May; 159(5):926-32. PubMed ID: 20435207
[TBL] [Abstract][Full Text] [Related]
19. Coronary perfusion: impact of flow dynamics and geometric design of 2 different aortic prostheses of similar size.
Mannacio V; Di Tommaso L; De Amicis V; Stassano P; Vosa C
J Thorac Cardiovasc Surg; 2012 May; 143(5):1030-5. PubMed ID: 21752400
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis.
Cam A; Goel SS; Agarwal S; Menon V; Svensson LG; Tuzcu EM; Kapadia SR
J Thorac Cardiovasc Surg; 2011 Oct; 142(4):800-8. PubMed ID: 21320709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
